Acute Kidney Injury Nursing Guide 2026: Staging, Causes, and Management

Part of the ICU Emergencies Hub — browse every related guide in one place.

This article was created with AI assistance.
Contents: AKI Staging (KDIGO) Types of AKI Nursing Assessment Management Priorities Nephrotoxin Avoidance Dialysis Indications and Nursing NCLEX High-Yield

AKI Staging (KDIGO Criteria)

AKI is defined by the KDIGO (Kidney Disease Improving Global Outcomes) criteria as ANY of the following:

StageCreatinine CriteriaUrine Output
Stage 11.5–1.9x baseline within 7 days OR ≥0.3 mg/dL rise within 48 hr<0.5 mL/kg/hr for 6–12 hr
Stage 22.0–2.9x baseline<0.5 mL/kg/hr for ≥12 hr
Stage 3≥3.0x baseline OR creatinine ≥4.0 mg/dL OR initiation of renal replacement therapy<0.3 mL/kg/hr for ≥24 hr OR anuria for ≥12 hr
Urine output is a more SENSITIVE early indicator of AKI than creatinine. Creatinine rises lag kidney injury by hours. A urine output <30 mL/hr (<0.5 mL/kg/hr for a 60 kg patient) requires immediate assessment.

Three Categories of AKI

CategoryMechanismCommon CausesKey Indicators
Prerenal AKI (~55%)Decreased renal perfusion without intrinsic kidney damage; kidneys are functionally intact but under-perfused; REVERSIBLE with fluid resuscitationHypovolemia (dehydration, hemorrhage, burns), cardiogenic shock, septic shock, hepatorenal syndrome, NSAIDs/ACE inhibitors reducing GFR, renal artery stenosisBUN/Cr ratio >20:1; urine Na <20 mEq/L; urine specific gravity >1.020; FENa <1%; concentrated urine (kidneys trying to conserve); responds to fluid challenge
Intrinsic (Intrarenal) AKI (~40%)Direct damage to renal parenchyma (tubules, glomeruli, interstitium, vasculature)ATN (acute tubular necrosis — most common intrinsic cause; ischemic or nephrotoxic); contrast nephropathy; aminoglycoside toxicity; glomerulonephritis; interstitial nephritis (NSAIDs, penicillin); rhabdomyolysisBUN/Cr ratio <15:1 (creatinine rises proportionally more); urine Na >40 mEq/L (kidneys can't reabsorb); FENa >2%; muddy brown casts (ATN); does NOT respond to fluids alone
Postrenal AKI (~5%)Obstruction to urine flow from the collecting system outward; relief of obstruction is curativeBPH (most common in elderly men), kidney stones, tumors (cervical, prostate, bladder), clots, strictures, neurogenic bladder, inadvertent ureteral ligation during surgeryBilateral hydronephrosis on ultrasound; symptoms of obstruction (difficulty voiding, distended bladder); immediate improvement after catheterization or stent placement

Nursing Assessment in AKI

AKI Management Priorities

Optimize Renal Perfusion

Manage Complications

ComplicationTreatment
HyperkalemiaCalcium gluconate (cardiac stabilization); insulin + D50 (shift K+ into cells); sodium bicarbonate; kayexalate or patiromer (excretion); dialysis if >6.5 or symptoms
Fluid overloadFluid restriction; loop diuretics (furosemide) if patient still makes urine; dialysis if refractory
Metabolic acidosisTreat underlying cause; sodium bicarbonate if pH <7.10 or HCO3 <10; dialysis
UremiaProtein restriction (controversial); dialysis is definitive for symptomatic uremia
HypertensionAntihypertensives (avoid ACE inhibitors/ARBs acutely — reduce GFR); fluid removal via dialysis or diuretics

Nephrotoxin Avoidance

AKI patients and those at risk (elderly, CKD, diabetes, sepsis, dehydration) should have ALL nephrotoxic agents reviewed and discontinued or minimized:
NephrotoxinMechanismNursing Action
NSAIDs (ibuprofen, ketorolac, naproxen)Inhibit prostaglandin-mediated renal afferent arteriole dilation → reduce GFR; especially dangerous in low-perfusion statesAVOID in AKI or at-risk patients; hold if creatinine rising; discontinue and use acetaminophen instead
ACE inhibitors / ARBs (lisinopril, losartan)Block angiotensin II-mediated efferent arteriole constriction → reduce GFR in renovascular/volume-depleted statesHold in acute AKI, sepsis, severe dehydration, or bilateral renal artery stenosis; restart when hemodynamically stable
IV Contrast dyeDirect tubular toxicity + renal vasoconstriction; highest risk in CKD, diabetes, dehydrationPre-hydrate with IV NS before and after contrast; minimize contrast volume; use iso-osmolar contrast; hold metformin 48 hr
Aminoglycosides (gentamicin, tobramycin)Direct tubular toxicity; accumulate in renal cortex; dose-dependent; non-oliguric ATNOnce-daily dosing preferred (less tubular accumulation); monitor trough levels; avoid concurrent nephrotoxins; assess renal function frequently; hydration
VancomycinNephrotoxicity especially with concurrent aminoglycosides or contrast; tubular toxicityMonitor vancomycin AUC/MIC (AUC-guided dosing replaces trough monitoring per 2020 ASHP guidelines); avoid concurrent aminoglycosides; optimize hydration

Dialysis Indications (AEIOU) and Nursing

Indications for Emergency Dialysis — AEIOU Mnemonic

Hemodialysis (HD) Nursing

NCLEX High-Yield Points

Get The ICU Notebook Newsletter

Clinical tools and career insights for ICU nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.